BACKGROUND: Breast-conserving surgery (BCS) has been the recommended treatment for early-stage breast cancer since 1990 yet many women still do not receive this procedure. OBJECTIVE: To examine the relationship between birthplace and use of BCS in Asian-American and Pacific-Islander (AAPI) women, and to determine whether disparities between white and AAPI women persist over time. DESIGN: Retrospective cohort study. SETTING AND PARTICIPANTS: Women with newly diagnosed stage I or II breast cancer from 1992 to 2000 in the Surveillance, Epidemiology, and End Results program. OUTCOME: Receipt of breast -conserving surgery for initial treatment of stage I or II breast cancer. MAIN RESULTS: Overall, AAPI women had lower rates of BCS than white women (47% vs 59%; P<.01). Foreign-born AAPI women had lower rates of BCS than U.S.-born AAPI and white women (43% vs 56% vs 59%; P<.01). After adjustment for age, marital status, tumor registry, year of diagnosis, stage at diagnosis, tumor size, histology, grade, and hormone receptor status, foreign-born AAPI women (adjusted OR [aOR], 0.49; 95% CI, 0.32 to 0.76) and U.S.-born AAPI women (aOR, 0.77; 95% CI, 0.62 to 0.95) had lower odds of receiving BCS than white women. Use of BCS increased over time for each racial/ethnic group; however, foreign-born AAPI women had persistently lower rates of BCS than non-Hispanic white women. CONCLUSIONS: AAPI women, especially those who are foreign born, are less likely to receive BCS than non-Hispanic white women. Of particular concern, differences in BCS use among foreign-born and U.S.-born AAPI women and non-Hispanic white women have persisted over time. These differences may reflect inequities in the treatment of early-stage breast cancer for AAPI women, particularly those born abroad.
BACKGROUND: Breast-conserving surgery (BCS) has been the recommended treatment for early-stage breast cancer since 1990 yet many women still do not receive this procedure. OBJECTIVE: To examine the relationship between birthplace and use of BCS in Asian-American and Pacific-Islander (AAPI) women, and to determine whether disparities between white and AAPI women persist over time. DESIGN: Retrospective cohort study. SETTING AND PARTICIPANTS: Women with newly diagnosed stage I or II breast cancer from 1992 to 2000 in the Surveillance, Epidemiology, and End Results program. OUTCOME: Receipt of breast -conserving surgery for initial treatment of stage I or II breast cancer. MAIN RESULTS: Overall, AAPI women had lower rates of BCS than white women (47% vs 59%; P<.01). Foreign-born AAPI women had lower rates of BCS than U.S.-born AAPI and white women (43% vs 56% vs 59%; P<.01). After adjustment for age, marital status, tumor registry, year of diagnosis, stage at diagnosis, tumor size, histology, grade, and hormone receptor status, foreign-born AAPI women (adjusted OR [aOR], 0.49; 95% CI, 0.32 to 0.76) and U.S.-born AAPI women (aOR, 0.77; 95% CI, 0.62 to 0.95) had lower odds of receiving BCS than white women. Use of BCS increased over time for each racial/ethnic group; however, foreign-born AAPI women had persistently lower rates of BCS than non-Hispanic white women. CONCLUSIONS: AAPI women, especially those who are foreign born, are less likely to receive BCS than non-Hispanic white women. Of particular concern, differences in BCS use among foreign-born and U.S.-born AAPI women and non-Hispanic white women have persisted over time. These differences may reflect inequities in the treatment of early-stage breast cancer for AAPI women, particularly those born abroad.
Authors: Angela W Prehn; Barbara Topol; Susan Stewart; Sally L Glaser; Lilia O'Connor; Dee W West Journal: Cancer Date: 2002-12-01 Impact factor: 6.860
Authors: Mita Sanghavi Goel; Christina C Wee; Ellen P McCarthy; Roger B Davis; Quyen Ngo-Metzger; Russell S Phillips Journal: J Gen Intern Med Date: 2003-12 Impact factor: 5.128
Authors: Quyen Ngo-Metzger; Ellen P McCarthy; Risa B Burns; Roger B Davis; Frederick P Li; Russell S Phillips Journal: Am J Med Date: 2003-07 Impact factor: 4.965
Authors: Roger T Anderson; Cyllene R Morris; Gretchen Kimmick; Amy Trentham-Dietz; Fabian Camacho; Xiao-Cheng Wu; Susan A Sabatino; Steven T Fleming; Joseph Lipscomb Journal: Cancer Date: 2014-11-04 Impact factor: 6.860
Authors: Scarlett Lin Gomez; Christina A Clarke; Sarah J Shema; Ellen T Chang; Theresa H M Keegan; Sally L Glaser Journal: Am J Public Health Date: 2010-03-18 Impact factor: 9.308
Authors: Signe Smith Nielsen; Yulei He; John Z Ayanian; Scarlett Lin Gomez; Katherine L Kahn; Dee W West; Nancy L Keating Journal: Cancer Date: 2010-07-29 Impact factor: 6.860
Authors: Dawn L Hershman; Lawrence H Kushi; Theresa Shao; Donna Buono; Aaron Kershenbaum; Wei-Yann Tsai; Louis Fehrenbacher; Scarlett Lin Gomez; Sunita Miles; Alfred I Neugut Journal: J Clin Oncol Date: 2010-06-28 Impact factor: 44.544
Authors: Shelley M Enger; Soe Soe Thwin; Diana S M Buist; Terry Field; Floyd Frost; Ann M Geiger; Timothy L Lash; Marianne Prout; Marianne Ulcickas Yood; Feifei Wei; Rebecca A Silliman Journal: J Clin Oncol Date: 2006-09-20 Impact factor: 44.544
Authors: Scarlett Lin Gomez; Daphne Lichtensztajn; Allison W Kurian; Melinda L Telli; Ellen T Chang; Theresa H M Keegan; Sally L Glaser; Christina A Clarke Journal: J Clin Oncol Date: 2010-02-16 Impact factor: 44.544